Biotech

All Articles

Basilea scores $268M BARDA financing for antifungals, anti-biotics

.Basilea Pharmaceutica's work creating brand new antifungals has obtained a substantial increase com...

Capricor offers Europe civil liberties to late-stage DMD treatment for $35M

.Possessing presently gathered up the united state legal rights to Capricor Therapeutics' late-stage...

FDA fragments adcomm for Applied's unusual condition medication

.After pushing the selection meeting for Applied Therapies' metabolic disorder medicine govorestat, ...

Novo inks $600M NanoVation offer to research genetic drugs ex-liver

.Novo Nordisk is actually continuing its press right into hereditary medicines, agreeing to compensa...

Innovent links cytokine to colon cancer feedbacks

.Innovent Biologics has created the situation that its own gate inhibitor-cytokine blend healthy pro...

Merck, Daiichi ADC strikes target in stage 3 lung cancer cells research study

.A period 3 test of Daiichi Sankyo as well as Merck &amp Co.'s HER3-directed antibody-drug conjugate...

Rakovina grows AI center with collab to select cancer cells intendeds

.5 months after Rakovina Therapeutics turned toward expert system, the cancer-focused biotech has ac...

Ascendis' dwarfism drug smash hits in stage 3, threatens BioMarin

.Ascendis Pharma has emerged as a prospective danger to BioMarin's Voxzogo, mentioning phase 3 growt...

Despite ph. 3 miss out on, Alkeus finds course ahead of time for eye health condition asset

.Though Alkeus Pharmaceuticals' dental eye disease resource fell short to considerably reduce geogra...

Kairos goes social with $6M IPO to fund tests of cancer cells drug

.Along with a trio of biotechs attacking the Nasdaq on Friday, it was very easy to miss out on a sma...